Bioorganic design of metal–organic frameworks for targeted and stimuli-responsive anticancer drug delivery
Bibliographic record
Abstract
No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.
Source: Not provided · Quality: missing
Research context
OpenAlex topics: Metal-Organic Frameworks: Synthesis and Applications · Nanoplatforms for cancer theranostics · Nanoparticle-Based Drug Delivery
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (100+)
Show source-provided references
1. Bray F, Laversanne M, Sung H et al (2024) Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 74(3):229–263. https://doi.org/10.3322/caac.2183410.3322/caac.21834 ↗
2. Zafar A, Khatoon S, Khan MJ et al (2025) Advancements and limitations in traditional anti-cancer therapies: a comprehensive review of surgery, chemotherapy, radiation therapy, and hormonal therapy. Discov Oncol 16(1):607. https://doi.org/10.1007/s12672-025-02198-810.1007/s12672-025-02198-8 ↗
3. Hopper C (2000) Photodynamic therapy: a clinical reality in the treatment of cancer. Lancet Oncol 1(4):212–219. https://doi.org/10.1016/s1470-2045(00)00166-210.1016/s1470-2045(00)00166-2 ↗
4. Mahvi DA, Liu R, Grinstaff MW et al (2018) Local cancer recurrence: the realities, challenges, and opportunities for new therapies. CA Cancer J Clin 68(6):488–505. https://doi.org/10.3322/caac.2149810.3322/caac.21498 ↗
5. Baldo BA, Pham NH (2013) Adverse reactions to targeted and non-targeted chemotherapeutic drugs with emphasis on hypersensitivity responses and the invasive metastatic switch. Cancer Metastasis Rev 32(3):723–76110.1007/s10555-013-9447-3 ↗
6. Yin ZS, Wang Z (2024) Strategies for engineering oncolytic viruses to enhance cancer immunotherapy. Front Pharmacol 15:1450203. https://doi.org/10.3389/fphar.2024.145020310.3389/fphar.2024.1450203 ↗
7. Wang K, Tepper JE (2021) Radiation therapy-associated toxicity: etiology, management, and prevention. CA Cancer J Clin 71(5):437–454. https://doi.org/10.3322/caac.2168910.3322/caac.21689 ↗
8. Kim BM, Hong Y, Lee S et al (2015) Therapeutic implications for overcoming radiation resistance in cancer therapy. Int J Mol Sci 16(11):26880–26913. https://doi.org/10.3390/ijms16112599110.3390/ijms161125991 ↗
9. Rau KM, Kang HY, Cha TL et al (2005) The mechanisms and managements of hormone-therapy resistance in breast and prostate cancers. Endocr Relat Cancer 12(3):511–532. https://doi.org/10.1677/erc.1.0102610.1677/erc.1.01026 ↗
10. Chaudhry P, Asselin E (2009) Resistance to chemotherapy and hormone therapy in endometrial cancer. Endocr Relat Cancer 16(2):363–380. https://doi.org/10.1677/ERC-08-026610.1677/ERC-08-0266 ↗
11. Sharma R, Komal K, Kumar S et al (2025) A comprehensive review on revolutionizing pancreatic cancer treatment: liposomal innovations. J Drug Deliv Sci Technol 110:107032. https://doi.org/10.1016/j.jddst.2025.10703210.1016/j.jddst.2025.107032 ↗
12. Tan S, Li D, Zhu X (2020) Cancer immunotherapy: pros, cons and beyond. Biomed Pharmacother 124:109821. https://doi.org/10.1016/j.biopha.2020.10982110.1016/j.biopha.2020.109821 ↗
13. Liu J, Huang J, Zhang L et al (2021) Multifunctional metal-organic framework heterostructures for enhanced cancer therapy. Chem Soc Rev 50(2):1188–1218. https://doi.org/10.1039/d0cs00178c10.1039/d0cs00178c ↗
14. Salehi MM, Esmailzadeh F, Hassanzadeh-Afruzi F (2023) Applications of MOFs. In: Maleki A, Taheri-Ledari R (eds) Physicochemical aspects of metal–organic Frameworks: a new class of coordinative materials. Springer, Cham, pp 197–30510.1007/978-3-031-18675-2_13 ↗
15. Altaf A, Khan I, Khan A et al (2024) Metal/covalent organic framework encapsulated lead-free halide perovskite hybrid nanocatalysts: Multifunctional applications, design, recent trends, challenges, and prospects. ACS Omega 9(32):34220–3424210.1021/acsomega.4c04532 ↗
16. Guo Z, Xiao Y, Wu W et al (2025) Metal–organic framework-based smart stimuli-responsive drug delivery systems for cancer therapy: advances, challenges, and future perspectives. J Nanobiotechnology 23(1):157. https://doi.org/10.1186/s12951-025-03252-x10.1186/s12951-025-03252-x ↗
17. Shano LB, Karthikeyan S, Kennedy LJ et al (2024) MOFs for next-generation cancer therapeutics through a biophysical approach-a review. Front Bioeng Biotechnol 12:1397804. https://doi.org/10.3389/fbioe.2024.139780410.3389/fbioe.2024.1397804 ↗
18. Cai M, Chen G, Qin L et al (2020) Metal organic frameworks as drug TARGETING delivery vehicles in the treatment of cancer. Pharmaceutics. https://doi.org/10.3390/pharmaceutics1203023210.3390/pharmaceutics12030232 ↗
19. Ashique S, Sandhu NK, Chawla V et al (2021) Targeted drug delivery: trends and perspectives. Curr Drug Deliv 18(10):1435–1455. https://doi.org/10.2174/156720181866621060916130110.2174/1567201818666210609161301 ↗
20. Al Bostami RD, Abuwatfa WH, Husseini GA (2022) Recent advances in nanoparticle-based co-delivery systems for cancer therapy. Nanomaterials 12(15):267210.3390/nano12152672 ↗
21. Sharma R, Kumar S, Komal K et al (2025) Comprehensive insights into pancreatic cancer treatment approaches and cutting-edge nanocarrier solutions: from pathology to nanomedicine. Naunyn Schmiedebergs Arch Pharmacol. https://doi.org/10.1007/s00210-025-04094-y10.1007/s00210-025-04094-y ↗
22. Wen T, Quan G, Niu B et al (2021) Versatile nanoscale metal–organic frameworks (nMOFs): an emerging 3D nanoplatform for drug delivery and therapeutic applications. Small 17(8):e2005064. https://doi.org/10.1002/smll.20200506410.1002/smll.202005064 ↗
23. Chen X, Argandona SM, Melle F et al (2024) Advances in surface functionalization of next-generation metal–organic frameworks for biomedical applications: design, strategies, and prospects. Chem 10(2):504–54310.1016/j.chempr.2023.09.016 ↗
24. Li B, Ashrafizadeh M, Jiao T (2024) Biomedical application of metal–organic frameworks (MOFs) in cancer therapy: stimuli-responsive and biomimetic nanocomposites in targeted delivery, phototherapy and diagnosis. Int J Biol Macromol 260:12939110.1016/j.ijbiomac.2024.129391 ↗
25. Giordano A, Provenza AC, Reverchon G et al (2024) Lipid-based nanocarriers: bridging diagnosis and cancer therapy. Pharmaceutics 16(9):1158. https://doi.org/10.3390/pharmaceutics1609115810.3390/pharmaceutics16091158 ↗
26. Han Y, Liu W, Huang J et al (2018) Cyclodextrin-based metal–organic frameworks (CD-MOFs) in pharmaceutics and biomedicine. Pharmaceutics 10(4):271. https://doi.org/10.3390/pharmaceutics1004027110.3390/pharmaceutics10040271 ↗
27. Nasrollahi M, Nabipour H, Valizadeh N et al (2020) The role of flexibility in MOFs. In: Mozafari M (ed) Metal–organic frameworks for biomedical applications. Woodhead Publishing, Cambridge, pp 93–110. https://doi.org/10.1016/b978-0-12-816984-1.00006-810.1016/b978-0-12-816984-1.00006-8 ↗
28. Kalmutzki MJ, Hanikel N, Yaghi OM (2018) Secondary building units as the turning point in the development of the reticular chemistry of MOFs. Sci Adv 4(10):eaat9180. https://doi.org/10.1126/sciadv.aat918010.1126/sciadv.aat9180 ↗
29. Lawson HD, Walton SP, Chan C (2021) Metal-organic frameworks for drug delivery: a design perspective. ACS Appl Mater Interfaces 13(6):7004–7020. https://doi.org/10.1021/acsami.1c0108910.1021/acsami.1c01089 ↗
30. Furukawa H, Cordova KE, O’Keeffe M et al (2013) The chemistry and applications of metal–organic frameworks. Science 341(6149):1230444. https://doi.org/10.1126/science.123044410.1126/science.1230444 ↗
31. Rojas S, Devic T, Horcajada P (2017) Metal organic frameworks based on bioactive components. J Mater Chem B 5(14):2560–2573. https://doi.org/10.1039/c6tb03217f10.1039/c6tb03217f ↗
32. Osterrieth JWM, Fairen-Jimenez D (2021) Metal–organic framework composites for theragnostics and drug delivery applications. Biotechnol J 16(2):e2000005. https://doi.org/10.1002/biot.20200000510.1002/biot.202000005 ↗
33. Abánades Lázaro I, Chen X, Ding M et al (2024) Metal–organic frameworks for biological applications. Nat Rev Methods Prim 4(1):4210.1038/s43586-024-00320-8 ↗
34. Sezgin P, Gulcay-Ozcan E, Vuckovski M et al (2025) Biomedical applications of metal-organic frameworks revisited. Ind Eng Chem Res 64(4):1907–1932. https://doi.org/10.1021/acs.iecr.4c0369810.1021/acs.iecr.4c03698 ↗
35. Arner EN, Rathmell JC (2023) Metabolic programming and immune suppression in the tumor microenvironment. Cancer Cell 41(3):421–433. https://doi.org/10.1016/j.ccell.2023.01.00910.1016/j.ccell.2023.01.009 ↗
36. Horcajada P, Serre C, Vallet-Regi M et al (2006) Metal-organic frameworks as efficient materials for drug delivery. Angew Chem Int Ed Engl 45(36):5974–5978. https://doi.org/10.1002/anie.20060187810.1002/anie.200601878 ↗
37. Gao L, Chen Q, Gong T et al (2019) Recent advancement of imidazolate framework (ZIF-8) based nanoformulations for synergistic tumor therapy. Nanoscale 11(44):21030–21045. https://doi.org/10.1039/c9nr06558j10.1039/c9nr06558j ↗
38. Sun Q, Bi H, Wang Z et al (2019) Hyaluronic acid-targeted and pH-responsive drug delivery system based on metal–organic frameworks for efficient antitumor therapy. Biomaterials 223:119473. https://doi.org/10.1016/j.biomaterials.2019.11947310.1016/j.biomaterials.2019.119473 ↗
39. Zhang J, Chen C, Li A et al (2021) Immunostimulant hydrogel for the inhibition of malignant glioma relapse post-resection. Nat Nanotechnol 16(5):538–548. https://doi.org/10.1038/s41565-020-00843-710.1038/s41565-020-00843-7 ↗
40. Xiong Y, Wang Y, Tiruthani K (2019) Tumor immune microenvironment and nano-immunotherapeutics in colorectal cancer. Nanomedicine 21:102034. https://doi.org/10.1016/j.nano.2019.10203410.1016/j.nano.2019.102034 ↗
41. Su H, Sun F, Jia J et al (2015) A highly porous medical metal–organic framework constructed from bioactive curcumin. Chem Commun 51(26):5774–5777. https://doi.org/10.1039/c4cc10159f10.1039/c4cc10159f ↗
42. Grall R, Hidalgo T, Delic J et al (2015) In vitro biocompatibility of mesoporous metal (III; Fe, Al, Cr) trimesate MOF nanocarriers. J Mater Chem B 3(42):8279–8292. https://doi.org/10.1039/c5tb01223f10.1039/c5tb01223f ↗
43. Tamames-Tabar C, Cunha D, Imbuluzqueta E et al (2014) Cytotoxicity of nanoscaled metal-organic frameworks. J Mater Chem B 2(3):262–271. https://doi.org/10.1039/c3tb20832j10.1039/c3tb20832j ↗
44. Gimenez-Marques M, Bellido E, Berthelot T et al (2018) GraftFast surface engineering to improve MOF nanoparticles furtiveness. Small 14(40):e1801900. https://doi.org/10.1002/smll.20180190010.1002/smll.201801900 ↗
45. Li B, Yao X, Li J et al (2023) A tumor microenvironment-activated metal–organic framework-based nanoplatform for amplified oxidative stress-induced enhanced chemotherapy. J Biol Chem 299(1):102742. https://doi.org/10.1016/j.jbc.2022.10274210.1016/j.jbc.2022.102742 ↗
46. Hua Y, Qin M, Lu S et al (2024) Hyaluronic acid-functionalized MOFs for combined sunitinib and siRNA therapy in renal cell carcinoma. Int J Biol Macromol 283(Pt 1):137317. https://doi.org/10.1016/j.ijbiomac.2024.13731710.1016/j.ijbiomac.2024.137317 ↗
47. Cunha D, Ben Yahia M, Hall S et al (2013) Rationale of drug encapsulation and release from biocompatible porous metal–organic frameworks. Chem Mater 25(14):2767–2776. https://doi.org/10.1021/cm400798p10.1021/cm400798p ↗
48. Sun Y, Zheng L, Yang Y et al (2020) Metal–organic framework nanocarriers for drug delivery in biomedical applications. Nano-Micro Lett 12(1):103. https://doi.org/10.1007/s40820-020-00423-310.1007/s40820-020-00423-3 ↗
49. Muslim M, Ali A, Ahmad M (2024) Hydrothermal synthesis of metal–organic frameworks. In: Azim Y, Rather SU, Bhawani SA, Bhatt PM (eds) Synthesis of metal–organic frameworks via water-based routes. Elsevier, Amsterdam, pp 73–9210.1016/B978-0-323-95939-1.00011-3 ↗
50. Mahmoud MM (2025) Microwave-assisted fast synthesis of MOF-801. Next Mater 6:10031610.1016/j.nxmate.2024.100316 ↗
51. Abaszadeh N, Afzali D, Sargazi G et al (2024) Sonochemical-assisted method for efficient synthesis of Cu-MOF and evaluating its antibacterial properties. Heliyon 10(10):e31024. https://doi.org/10.1016/j.heliyon.2024.e3102410.1016/j.heliyon.2024.e31024 ↗
52. Letwaba J, Uyor UO, Mavhungu ML et al (2024) A review on MOFs synthesis and effect of their structural characteristics for hydrogen adsorption. RSC Adv 14(20):14233–1425310.1039/D4RA00865K ↗
53. Kumari S, Gusain M, Lamba BY et al (2025) A critical review on recent advancements in metal–organic frameworks for CO2 capture, storage and utilization. J Mater Chem A 13:21352–2138810.1039/D5TA02338F ↗
54. Vaid TP, Kelley SP, Rogers RD (2017) Structure-directing effects of ionic liquids in the ionothermal synthesis of metal-organic frameworks. IUCrJ 4(Pt 4):380–392. https://doi.org/10.1107/S205225251700832610.1107/S2052252517008326 ↗
55. Cui J, Gao N, Yin X et al (2018) Microfluidic synthesis of uniform single-crystalline MOF microcubes with a hierarchical porous structure. Nanoscale 10(19):9192–9198. https://doi.org/10.1039/c8nr01219a10.1039/c8nr01219a ↗
56. Zhu Z, Ouyang Q, Zhou L et al (2025) Current status and prospects of detection of breast cancer by MOFs platform. J Mol Struct 1321:13979710.1016/j.molstruc.2024.139797 ↗
57. Umar S, Samokhvalov A (2024) Encapsulation of gemcitabine on porphyrin aluminum metal–organic framework by mechano-chemistry, delayed drug release and cytotoxicity to pancreatic cancer PANC-1 cells. Molecules 29(13):3189. https://doi.org/10.3390/molecules2913318910.3390/molecules29133189 ↗
58. Zhang T, Sun Y, Cao J et al (2021) Intrinsic nucleus-targeted ultra-small metal–organic framework for the type I sonodynamic treatment of orthotopic pancreatic carcinoma. J Nanobiotechnology 19(1):315. https://doi.org/10.1186/s12951-021-01060-710.1186/s12951-021-01060-7 ↗
59. Sakamaki Y, Ozdemir J, Heidrick Z et al (2021) A bio-conjugated chlorin-based metal–organic framework for targeted photodynamic therapy of triple negative breast and pancreatic cancers. ACS Appl Bio Mater 4(2):1432–1440. https://doi.org/10.1021/acsabm.0c0132410.1021/acsabm.0c01324 ↗
60. Sun Y, Cao J, Wang X et al (2021) Hypoxia-adapted sono-chemodynamic treatment of orthotopic pancreatic carcinoma using copper metal–organic frameworks loaded with an ultrasound-induced free radical initiator. ACS Appl Mater Interfaces 13(32):38114–38126. https://doi.org/10.1021/acsami.1c1101710.1021/acsami.1c11017 ↗
61. Liu J, Yang L, Cao X et al (2021) PEGylated Mn containing MOF nanoparticles for potential immunotherapy of pancreatic cancer via manganese induced activation of anti-tumor immunity. Colloid Interface Sci Commun 42:100409. https://doi.org/10.1016/j.colcom.2021.10040910.1016/j.colcom.2021.100409 ↗
62. Eskandari A, Wang Y, Forgan RS. Potent activity of Metal–organic Framework nanoparticles loaded by hydrophobic natural products via one-pot synthetic method against pancreatic cancers. 202310.26434/chemrxiv-2023-mhb04 ↗
63. Nekoufar S, Ghorbani M, Safaei S et al (2025) Exploring the potential of gemcitabine-metal–organic frameworks in combating pancreatic cancer under ketogenic conditions. BMC Cancer 25(1):53. https://doi.org/10.1186/s12885-024-13397-x10.1186/s12885-024-13397-x ↗
64. Mady FM, Essa H, El-Ammawi T et al (2016) Formulation and clinical evaluation of silymarin pluronic-lecithin organogels for treatment of atopic dermatitis. Drug Des Devel Ther 10:1101–1110. https://doi.org/10.2147/DDDT.S10342310.2147/DDDT.S103423 ↗
65. Lu K, He C, Lin W (2015) A chlorin-based nanoscale metal–organic framework for photodynamic therapy of colon cancers. J Am Chem Soc 137(24):7600–7603. https://doi.org/10.1021/jacs.5b0406910.1021/jacs.5b04069 ↗
66. Jiang H, Bao Q, Yang T et al (2024) Precision treatment of colon cancer using doxorubicin-loaded metal–organic-framework-coated magnetic nanoparticles. ACS Appl Mater Interfaces 16(37):49003–49012. https://doi.org/10.1021/acsami.4c0860210.1021/acsami.4c08602 ↗
67. Duan F, Hu M, Guo C et al (2020) Chromium-based metal–organic framework embedded with cobalt phthalocyanine for the sensitively impedimetric cytosensing of colorectal cancer (CT26) cells and cell imaging. Chem Eng J 398:12545210.1016/j.cej.2020.125452 ↗
68. Wang W, Wang L, Li Y et al (2016) Nanoscale polymer metal–organic framework hybrids for effective photothermal therapy of colon cancers. Adv Mater 28(42):9320–9325. https://doi.org/10.1002/adma.20160299710.1002/adma.201602997 ↗
69. Hang L, Li M, Zhang Y et al (2024) Mn(II) optimized sono/chemodynamic effect of porphyrin-metal–organic framework nanosheets for MRI-guided colon cancer therapy and metastasis suppression. Small 20(15):e2306364. https://doi.org/10.1002/smll.20230636410.1002/smll.202306364 ↗
70. Padya BS, Fernandes G, Hegde S et al (2023) Targeted delivery of 5-fluorouracil and sonidegib via surface-modified ZIF-8 MOFs for Effective basal cell carcinoma therapy. Pharmaceutics 15(11):2594. https://doi.org/10.3390/pharmaceutics1511259410.3390/pharmaceutics15112594 ↗
71. Sun X, Wang Q, Bao H et al (2024) Porphyrinic metal–organic framework PCN-224 nanoparticles for colocalization of nanoparticle-cargo in the skin and enhancement of sonodynamic efficacy. ACS Appl Nano Mater 7(3):2614–2629. https://doi.org/10.1021/acsanm.3c0467510.1021/acsanm.3c04675 ↗
72. Ebrahimpour A, Riahi Alam N, Abdolmaleki P et al (2020) Magnetic metal–organic framework based on zinc and 5-aminolevulinic acid: MR imaging and brain tumor therapy. J Inorg Organomet Polym Mater 31(3):1208–1216. https://doi.org/10.1007/s10904-020-01782-510.1007/s10904-020-01782-5 ↗
73. Lee S, Kim YY, Ahn HJ (2021) Systemic delivery of CRISPR/Cas9 to hepatic tumors for cancer treatment using altered tropism of lentiviral vector. Biomaterials 272:120793. https://doi.org/10.1016/j.biomaterials.2021.12079310.1016/j.biomaterials.2021.120793 ↗
74. Chen L, Yu H, Li Y et al (2018) Fabrication of a microporous Dy(III)-organic framework with polar channels for 5-Fu (fluorouracil) delivery and inhibiting human brain tumor cells. Struct Chem 29(6):1885–1891. https://doi.org/10.1007/s11224-018-1168-310.1007/s11224-018-1168-3 ↗
75. Sharma A, Kumar A, Li C et al (2021) A cannabidiol-loaded Mg-gallate metal-organic framework-based potential therapeutic for glioblastomas. J Mater Chem B 9(10):2505–2514. https://doi.org/10.1039/d0tb02780d10.1039/d0tb02780d ↗
76. Pandya I, Kumar S, Aswal VK et al (2024) Metal organic framework-based polymeric hydrogel: a promising drug delivery vehicle for the treatment of breast cancer. Int J Pharm 658:124206. https://doi.org/10.1016/j.ijpharm.2024.12420610.1016/j.ijpharm.2024.124206 ↗
77. Li H, Zhang Y, Liang L et al (2022) Doxorubicin-loaded metal–organic framework nanoparticles as acid-activatable hydroxyl radical nanogenerators for enhanced chemo/chemodynamic synergistic therapy. Materials 15(3):109610.3390/ma15031096 ↗
78. Aldawsari MF, Anwer MK (2025) Synthesis of acalabrutinib loaded β-cyclodextrin-based metal–organic frameworks as a potential material for breast cancer therapy. Results Chem 16:102512. https://doi.org/10.1016/j.rechem.2025.10251210.1016/j.rechem.2025.102512 ↗
79. Javazm AB, Kashani GK, Matini A et al (2025) Label-free polyethylenimine@carbon quantum dots@Ni-metal–organic frameworks biosensing platform for highly sensitive detection of HER2-positive breast cancer biomarker. Microchem J 215:114120. https://doi.org/10.1016/j.microc.2025.11412010.1016/j.microc.2025.114120 ↗
80. Soman S, Kulkarni S, Vineeth P et al (2024) Harnessing nanotechnology for breast cancer management: UiO-66 (NH2) metal–organic frameworks functionalized with chitosan and folic acid for the efficient delivery of doxorubicin. Nano Struct Nano Objects 40:10136010.1016/j.nanoso.2024.101360 ↗
81. Fereydouni P, Al Mohaddesin A, Khaleghi S (2024) Targeted biocompatible Zn-metal–organic framework nanocomposites for intelligent chemotherapy of breast cancer cells. Sci Rep 14(1):18311. https://doi.org/10.1038/s41598-024-69457-610.1038/s41598-024-69457-6 ↗
82. Yu C-H, Hermosa GC, Sun A-C et al (2024) Monacolin-K loaded MIL-100(Fe) metal–organic framework induces ferroptosis on metastatic triple-negative breast cancer. Chem Eng J 498:154751. https://doi.org/10.1016/j.cej.2024.15475110.1016/j.cej.2024.154751 ↗
83. Xu Z, Zhou Z, Yang X et al (2024) Determining M2 macrophages content for the anti-tumor effects of metal–organic framework-encapsulated pazopanib nanoparticles in breast cancer. J Nanobiotechnol 22(1):429. https://doi.org/10.1186/s12951-024-02694-z10.1186/s12951-024-02694-z ↗
84. Singhal M, Riches-Suman K, Pors K et al (2024) Encapsulation and delivery of mitoxantrone using zirconium-based metal–organic frameworks (MOFs) and their cytotoxic potential in breast cancer cells. Appl Sci 14(5):190210.3390/app14051902 ↗
85. Gravan P, Rojas S, Picchi DF et al (2024) Towards a more efficient breast cancer therapy using active human cell membrane-coated metal–organic frameworks. Nanomaterials 14(9):784. https://doi.org/10.3390/nano1409078410.3390/nano14090784 ↗
86. Basha SS, Sasmal A, Ariraman S et al (2025) Cobalt-nickel metal–organic frameworks (CNM) as Drug delivery agent for triple-negative breast cancer. Nanoscale Adv 7:5361–537610.1039/D5NA00193E ↗
87. Abu Saleem E, Lafi Z, Shalan N et al (2025) Formation and evaluation of doxorubicin and cromoglycate metal-organic framework for anti-cancer activity. Nanomedicine 20(5):467–479. https://doi.org/10.1080/17435889.2025.245905910.1080/17435889.2025.2459059 ↗
88. Aldawsari MF, Anwer MK (2025) Synthesis of acalabrutinib loaded β-cyclodextrin-based metal–organic frameworks as a potential material for breast cancer therapy. Results Chem 16:10251210.1016/j.rechem.2025.102512 ↗
89. Sun L, Gao H, Wang H et al (2024) Nanoscale metal–organic frameworks-mediated degradation of mutant p53 proteins and activation of cGAS-STING pathway for enhanced cancer immunotherapy. Adv Sci 11(12):e2307278. https://doi.org/10.1002/advs.20230727810.1002/advs.202307278 ↗
90. Huang S, Yuan J, Xie Y et al (2023) Targeting nano-regulator based on metal–organic frameworks for enhanced immunotherapy of bone metastatic prostate cancer. Cancer Nanotechnol 14(1):43. https://doi.org/10.1186/s12645-023-00200-y10.1186/s12645-023-00200-y ↗
91. Hu J, Hu J, Wu W et al (2022) N-acetyl-galactosamine modified metal-organic frameworks to inhibit the growth and pulmonary metastasis of liver cancer stem cells through targeted chemotherapy and starvation therapy. Acta Biomater 151:588–599. https://doi.org/10.1016/j.actbio.2022.08.02710.1016/j.actbio.2022.08.027 ↗
92. Li XY, Guan QX, Shang YZ et al (2021) Metal-organic framework IRMOFs coated with a temperature-sensitive gel delivering norcantharidin to treat liver cancer. World J Gastroenterol 27(26):4208–4220. https://doi.org/10.3748/wjg.v27.i26.420810.3748/wjg.v27.i26.4208 ↗
93. Raju P, Balakrishnan K, Mishra M et al (2022) Fabrication of pH responsive FU@ Eu-MOF nanoscale metal organic frameworks for lung cancer therapy. J Drug Deliv Sci Technol 70:10322310.1016/j.jddst.2022.103223 ↗
94. He Y, Xiong T, He S et al (2021) Pulmonary targeting crosslinked cyclodextrin metal–organic frameworks for lung cancer therapy. Adv Funct Mater 31(3):200455010.1002/adfm.202004550 ↗
95. Xiong T, Guo T, He Y et al (2023) Lactone stabilized by crosslinked cyclodextrin metal–organic frameworks to improve local bioavailability of topotecan in lung cancer. Pharmaceutics 15(1):14210.3390/pharmaceutics15010142 ↗
96. Wei D, Xin Y, Rong Y et al (2019) A mesoporous Gd-MOF with Lewis basic sites for 5-Fu delivery and inhibition of human lung cancer cells In Vivo and In Vitro. J Inorg Organomet Polym Mater 30(4):1121–1131. https://doi.org/10.1007/s10904-019-01305-x10.1007/s10904-019-01305-x ↗
97. Li D, Li L-F, Zhang Z-F et al (2020) Ultrasound-assisted synthesis of a new nanostructured Ca(II)-MOF as 5-FU delivery system to inhibit human lung cancer cell proliferation, migration, invasion and induce cell apoptosis. J Coord Chem 73(2):266–281. https://doi.org/10.1080/00958972.2020.172789510.1080/00958972.2020.1727895 ↗
98. Tian X, Yang L, Li Q et al (2025) Barbiturate derivative JL1 encapsulated with a hafnium-based MOF in poly(N-isopropylacrylamide) for non-small cell lung cancer therapy. ACS Appl Nano Mater 8(6):2926–2939. https://doi.org/10.1021/acsanm.4c0659710.1021/acsanm.4c06597 ↗
99. Wu MX, Yang YW (2017) Metal–organic framework (MOF)‐based drug/cargo delivery and cancer therapy. Adv Mater 29(23):160613410.1002/adma.201606134 ↗
100. Sadiq S, Khan S, Khan I et al (2024) A critical review on metal–organic frameworks (MOFs) based nanomaterials for biomedical applications: designing, recent trends, challenges, and prospects. Heliyon 10(3):e25521. https://doi.org/10.1016/j.heliyon.2024.e2552110.1016/j.heliyon.2024.e25521 ↗